AMPLEXA GENETICS A/S: Financial statements 2014
CVR: 29428441
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -185,712 and a net result of DKK -3,386,966 compared with DKK -5,860,653 the year before. Equity in the 2014 report amounted to DKK -16,208,837.
- Gross Profit
- DKK -185,712
- Profit/Loss
- DKK -3,386,966
- Equity
- DKK -16,208,837
- Total Assets
- DKK 3,036,615
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -186 t. | -3.4 mio. | -16.2 mio. | - |
| 2013 | - | -786 t. | -5.9 mio. | -12.8 mio. | - |
| 2012 | - | -538 t. | -2.1 mio. | -7 mio. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
AMPLEXA GENETICS A/S has published its annual report for 2013. Gross profit came to DKK -785,662, and the net result was DKK -5,860,653.
About AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The board consists of Magnus Herdalur (chair), Eydfinn Reydberg and Ulf Bech Christensen. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity in the 2025 report amounted to DKK -10,313,267.